CA
CalciMedica, Inc. (CALC)
NASDAQ·Healthcare·Biotechnology
$2.00
-5.66%
Mkt Cap $9.29M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$266.00
Range $14.00 – $392.00
Implied Upside
+13200.0%
Consensus $266.00 vs current $2.00
NASDAQ·Healthcare·Biotechnology
$2.00
-5.66%
Mkt Cap $9.29M
No recent rating data.
Price Target (3 analysts)
$266.00
Range $14.00 – $392.00
+13200.0%
Consensus $266.00 vs current $2.00